[
  {
    "variant_id": {
      "Gene": "INS",
      "Protein_Change": {
        "ref": "R",
        "alt": "T",
        "position": "54"
      },
      "variant_string_id": "INS R54T"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper describes that insulin signaling involves interactions between INS and IRS1, which are disrupted by certain variants.",
        "judgment": "Yes",
        "reasoning": "The disease mechanism is clearly defined as impaired insulin signaling due to disrupted interaction with IRS1."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "Co-immunoprecipitation (Co-IP) assays were used to assess protein-protein interactions, which directly model the disease mechanism.",
        "judgment": "Yes",
        "reasoning": "The Co-IP assay effectively models the disruption of INS-IRS1 interaction, which is central to the disease mechanism."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "Basic controls (wild-type INS) and replicates (n=3) were included.",
        "judgment": "Yes",
        "reasoning": "Both basic controls and replicates were used, satisfying the requirements for Sub-step 3a."
      },
      {
        "step_name": "Sub-step 3c: Variant Controls",
        "extracted_paper_info": "No known pathogenic or benign variants were explicitly tested as controls.",
        "judgment": "No",
        "reasoning": "Variant controls (known pathogenic/benign) were not used, limiting the strength of the evidence."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_supporting"
    },
    "overall_conclusion": "The variant R54T disrupts INS-IRS1 interaction and insulin signaling, supporting its classification as Pathogenic. However, the lack of statistical analysis or variant controls limits the strength to supporting."
  },
  {
    "variant_id": {
      "Gene": "INS",
      "Protein_Change": {
        "ref": "K",
        "alt": "M",
        "position": "38"
      },
      "variant_string_id": "INS K38M"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper describes that insulin signaling involves interactions between INS and IRS1, which are disrupted by certain variants.",
        "judgment": "Yes",
        "reasoning": "The disease mechanism is clearly defined as impaired insulin signaling due to disrupted interaction with IRS1."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "Co-immunoprecipitation (Co-IP) assays were used to assess protein-protein interactions, which directly model the disease mechanism.",
        "judgment": "Yes",
        "reasoning": "The Co-IP assay effectively models the disruption of INS-IRS1 interaction, which is central to the disease mechanism."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "Basic controls (wild-type INS) and replicates (n=3) were included.",
        "judgment": "Yes",
        "reasoning": "Both basic controls and replicates were used, satisfying the requirements for Sub-step 3a."
      },
      {
        "step_name": "Sub-step 3c: Variant Controls",
        "extracted_paper_info": "No known pathogenic or benign variants were explicitly tested as controls.",
        "judgment": "No",
        "reasoning": "Variant controls (known pathogenic/benign) were not used, limiting the strength of the evidence."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_supporting"
    },
    "overall_conclusion": "The variant K38M disrupts INS-IRS1 interaction and insulin signaling, supporting its classification as Pathogenic. However, the lack of statistical analysis or variant controls limits the strength to supporting."
  }
]